Quantcast

Latest vemurafenib Stories

2015-06-01 08:33:59

- Differentiated safety profile emerging relative to other MEK/BRAF combination therapies - BOULDER, Colo., June 1, 2015 /PRNewswire/ -- Array BioPharma's wholly-owned MEK inhibitor,

2015-05-19 08:40:34

DALLAS, May 19, 2015 /PRNewswire/ -- This melanoma treatment market (therapeutics) report analyzes treatment usage patterns, drug types available and pipeline and market

2015-01-23 08:25:18

- Array to receive global rights from Novartis to innovative BRAF inhibitor - BOULDER, Colo., Jan. 23, 2015 /PRNewswire/ -- Array BioPharma Inc.

2014-10-29 00:21:55

LONDON, Oct.

2014-09-29 08:30:43

- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept.

2014-09-18 12:29:43

The Highest Percentage of Non-Prescribers Anticipate Prescribing Tafinlar and Mekinist Within the Next One to Three Months, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-08-12 08:30:30

SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that K.


Word of the Day
gubbings
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'